Mariusz Pytkowski Selected Research

Electric Countershock (Cardioversion)

1/2023	The Comparative Effectiveness and Safety of Different Anticoagulation Strategies for Treatment of Left Atrial Appendage Thrombus in the Setting of Chronic Anticoagulation for Atrial Fibrillation or Flutter.
1/2022	Rapid pharmacological cardioversion of recent-onset atrial fibrillation using antazoline in elderly patients.
1/2019	Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
12/2018	Clinical effectiveness and safety of antazoline-based therapy in patients with stable coronary artery disease undergoing pharmacological cardioversion of short-duration atrial fibrillation in the emergency department.
10/2017	Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
6/2016	Comparative effectiveness and safety of antazoline‑based and propafenone‑based strategies for pharmacological cardioversion of short‑duration atrial fibrillation in the emergency department.
9/2012	Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation--a protocol of a single center, randomized, double-blind, placebo-controlled study (the AnPAF Study).
12/2008	Paroxysmal atrial fibrillation is associated with increased intra-atrial conduction delay.
10/2002	Risk of thromboembolic complications in patients with permanent atrial fibrillation undergoing cardioverter-defibrillator implantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariusz Pytkowski Research Topics

Disease

11	Atrial Fibrillation 01/2023 - 10/2002
7	Heart Failure 01/2022 - 04/2004
6	Cardiac Arrhythmias (Arrythmia) 10/2022 - 04/2012
5	Ventricular Tachycardia 10/2022 - 12/2003
4	Ventricular Fibrillation 10/2022 - 03/2006
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2010 - 10/2005
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2019 - 10/2005
2	Thrombosis (Thrombus) 01/2023 - 10/2005
2	Heart Diseases (Heart Disease) 10/2022 - 01/2022
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 04/2012
2	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2021 - 01/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2018 - 09/2014
2	Reciprocating Tachycardia 11/2016 - 12/2014
2	Supraventricular Tachycardia 12/2014 - 09/2010
2	Myocardial Infarction 01/2012 - 03/2006
1	Carcinogenesis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Atrial Flutter (Flutter, Atrial) 01/2020
1	Infections 01/2020
1	Systolic Heart Failure 12/2018
1	Tachycardia (Tachyarrhythmias) 10/2017
1	Pulmonary Embolism 01/2016
1	Endocarditis 07/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Hemorrhage 10/2002

Drug/Important Bio-Agent (IBA)

5	Antazoline (Antazoline Phosphate)FDA Link 01/2022 - 09/2012
2	Mexiletine (Mexitil)FDA LinkGeneric 10/2022 - 01/2017
2	Anti-Arrhythmia AgentsIBA 10/2022 - 09/2012
2	Amiodarone (Amiodarona)FDA LinkGeneric 12/2018 - 01/2017
2	vernakalantIBA 12/2018 - 09/2012
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 04/2021
1	ORALIT (ORS)IBA 09/2015
1	Adenosine Triphosphate (ATP)IBA 09/2014
1	butaneIBA 03/2006
1	Heparin (Liquaemin)FDA LinkGeneric 10/2005

Therapy/Procedure

10	Therapeutics 01/2023 - 10/2002
9	Electric Countershock (Cardioversion) 01/2023 - 10/2002
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2022 - 10/2005
6	Catheter Ablation 01/2022 - 12/2003
6	Radiofrequency Ablation 01/2020 - 09/2010
3	Defibrillators (Defibrillator) 03/2006 - 10/2002
2	Catheters 01/2021 - 01/2020
2	Cardiac Resynchronization Therapy 12/2018 - 10/2014
1	Contraindications 01/2016
1	Cardiac Resynchronization Therapy Devices 10/2014
1	Secondary Prevention 09/2010